🟢 TransMedics Group is trading 10.12% up as major indexes rise more than 1.7%

TransMedics Group is trading at $73.53, up +10.12%, amid broad market strength, with major indexes up more than 1.7%—the likeliest available explanation for the move.

• No confirmed company-specific announcement explaining the November 4 move appeared in available search results.
• The scheduled Q3 report is November 5 after market close; a November 4 preview highlighted analysts’ estimates.